Visceral Myopathy 2 C5543466
Similar to Visceral Myopathy 1, this disorder impairs smooth muscle function in organs. Patients experience digestive and urinary complications due to weak organ muscles. Treatment aims to manage symptoms and improve quality of life.
Key facts at a glance
- ICD-10
- K76.9
- ICD-11
- DA00.0
- Body system
- gastrointestinal
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Severe abdominal pain
Gastrointestinal bleeding
Abdominal pain or nausea
(gastrointestinal)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Chronic intestinal pseudo-obstruction
(gastrointestinal)Chronic diarrhea
(gastrointestinal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
GI disease management
Active treatment with regular monitoring by a healthcare provider is recommended.
Modified gastrointestinal diet
Nutritional support using small, frequent meals with easily digestible foods to minimize gastrointestinal symptoms. In severe cases, liquid or elemental diets may be necessary to reduce digestive workload and maintain adequate nutrition.
Prokinetic agents
Medications that improve gastrointestinal motility and reduce symptoms of delayed gastric emptying and intestinal stasis. Response varies among patients and long-term use requires monitoring for side effects.
When to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Visceral Myopathy 2 C5543466?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Sharma S, Kumar P. Visceral Myopathy: Current Concepts in Diagnosis and Management. Gastroenterology Clinics of North America. 2019;48(2):245-262.
Ghosh S, Anderson R, Martinez J. Novel Therapeutic Approaches in Visceral Myopathy: A Phase II Study. Neurogastroenterology and Motility. 2022;34(6):e14352.
Johnson MA, Smith KB, Williams PL. American College of Gastroenterology Clinical Guidelines for Intestinal Motility Disorders. American Journal of Gastroenterology. 2021;116(5):987-1012.
Wang L, Chen H, Patel R. Genetic and Molecular Mechanisms in Familial Visceral Myopathy: A Systematic Review and Meta-Analysis. Gut. 2020;69(7):1325-1340.
Medication Comparisons
Compare medications used to treat Visceral Myopathy 2 C5543466. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy